Guardian Pharmacy Services (NYSE:GRDN) Stock Price Expected to Rise, Truist Financial Analyst Says

Guardian Pharmacy Services (NYSE:GRDN) had its price objective hoisted by Truist Financial from $22.00 to $24.00 in a research note released on Friday,Benzinga reports. Truist Financial currently has a buy rating on the stock.

GRDN has been the subject of several other reports. Raymond James started coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They set an “outperform” rating and a $21.00 price objective for the company. Stephens initiated coverage on shares of Guardian Pharmacy Services in a report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 target price for the company.

Guardian Pharmacy Services Trading Up 2.0 %

GRDN stock opened at $21.34 on Friday. Guardian Pharmacy Services has a 52 week low of $14.16 and a 52 week high of $23.05.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million during the quarter, compared to analysts’ expectations of $303.21 million. On average, equities analysts anticipate that Guardian Pharmacy Services will post 0.81 earnings per share for the current year.

Insiders Place Their Bets

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was acquired at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the purchase, the director now owns 35,714 shares of the company’s stock, valued at $499,996. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Institutional Investors Weigh In On Guardian Pharmacy Services

Institutional investors have recently bought and sold shares of the stock. Stephens Inc. AR bought a new position in shares of Guardian Pharmacy Services during the third quarter valued at about $189,000. Barclays PLC purchased a new position in shares of Guardian Pharmacy Services in the 3rd quarter worth approximately $311,000. Point72 DIFC Ltd bought a new position in shares of Guardian Pharmacy Services in the third quarter valued at approximately $573,000. Royce & Associates LP purchased a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $1,260,000. Finally, Foundry Partners LLC bought a new stake in Guardian Pharmacy Services during the third quarter worth $1,680,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.